View:
----------------------------------- OMB APPROVAL ----------------------------------- OMB Number:............323-0145 ----------------------------------- UNITED STATES Expires: December 31, 1997 SECURITIES AND EXCHANGE COMMISSION Estimated average burden Washington, D.C. 20549 hours per response........14.90 ----------------------------------- SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 ) ---------- Landec Corporation - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 514766104 ------------------------------------------------------- (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 10 Pages - -------------------------------------------------------------------------------- CUSIP No. 514766100 SCHEDULE 13G Page 2 of 10 Pages --------- ----- ----- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Chase Venture Capital Associates, L.P. (f/k/a/ Chemical Venture Capital Associates, A California Limited Partnership) 13-337-6808 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION California - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF 1,306,817 SHARES BENEFICIALLY ------------------------------------------------------- OWNED BY 6 SHARED VOTING POWER EACH 35,434 REPORTING ------------------------------------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH 1,306,817 ------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 35,434 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,342,251 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11.9% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Page 2 of 10 Pages SCHEDULE 13G ------------ Issuer: Landec Corporation CUSIP Number: 514766100 - ------ ------------ - -------------------------------------------------------------------------------- Item 1. (a) Name of Issuer: --------------- Landec Corporation (b) Address of Issuer's Principal Executive Offices: ------------------------------------------------ 3603 Haven Avenue Menlo Park, California 94025 Item 2. (a) Name of Person Filing: ---------------------- Chase Venture Capital Associates, L.P. (f/k/a Chemical Venture Capital Associates, A California Limited Partnership) Supplemental information relating to the ownership and control of the person filing this statement is included in Exhibit 2(a) attached hereto. (b) Address of Principal Business Office or, if none, Residence: ------------------------------------------------------------ 380 Madison Avenue, 12th Floor New York, New York 10017 (c) Citizenship: ------------ See Row 4 on cover page (d) Title of Class of Securities (of Issuer): ----------------------------------------- Common Stock (e) CUSIP Number: ------------- See top of cover page Item 3. If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b), check whether the person filing is a: Not applicable. Item 4. Ownership (a) Amount Beneficially Owned: -------------------------- 42,251. This amount includes the following shares issuable upon the exercise by Mitchell Blutt, M.D. and Damion E. Wicker, M.D., directors of the Issuer, of options granted to them by the Issuer: (i) 3,478 shares issuable pursuant to options which became exercisable at a rate of 1/48 monthly from December 14, 1993 so long as Dr. Blutt remains a director of the Issuer, (ii) 3,478 shares issuable pursuant to options which became exercisable at a rate of 1/4 at May 25, 1996 and 1/48 per month thereafter so long as Dr. Blutt remains a director of the Issuer, (iii) 5,000 shares issuable pursuant to options which became Page 3 of 10 Pages SCHEDULE 13G ------------ Issuer: Landec Corporation CUSIP Number: 514766100 - ------ ------------ - -------------------------------------------------------------------------------- exercisable at a rate of 1/4 at January 26, 1997 and 1/48 per month thereafter as long as Dr. Blutt remains a director of the Issuer, (iv) 3,478 shares issuable pursuant to options granted to Dr. Wicker which are exercisable immediately, and (v) 20,000 shares issuable pursuant to options which are exercisable immediately so long as Dr. Wicker remains a director of the Issuer. Drs. Blutt and Wicker are obligated to exercise each of the foregoing options upon the request of the Reporting Person and are obligated to transfer to the Reporting Person all shares issued upon the exercise of any of the foregoing options. (b) Percent of Class: ----------------- 11.9% (c) Number of shares as to which such person has: --------------------------------------------- (i) 1,306,817 (ii) 35,434 (iii) 1,306,817 (iv) 35,434 Item 5. Ownership of Five Percent or Less of a Class Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of Group Not applicable. Item 10. Certification Not applicable. Page 4 of 10 Pages SCHEDULE 13G ------------ Issuer: Landec Corporation CUSIP Number: 514766100 - ------ ------------ - -------------------------------------------------------------------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 1998 CHASE VENTURE CAPITAL ASSOCIATES, L.P. By: CHASE CAPITAL PARTNERS, its General Partner By: /s/ Jeffrey C. Walker --------------------------------- Name: Jeffrey C. Walker Title: Managing General Partner Page 5 of 10 Pages SCHEDULE 13G ------------ Issuer: Landec Corporation CUSIP Number: 514766100 - ------ ------------ - -------------------------------------------------------------------------------- EXHIBIT 2(a) ------------ This statement is being filed by Chase Venture Capital Associates, L.P. (f/k/a Chemical Venture Capital Associates, A California Limited Partnership) (hereinafter referred to as "CVCA"), whose principal business office is located at 380 Madison Avenue, 12th Floor, New York, New York 10017. The general partner of CVCA is Chase Capital Partners (f/k/a Chemical Venture Partners), a New York general partnership ("CCP"), whose principal business office is located at the same address as CVCA. Set forth below are the names of each general partner of CCP who is a natural person. Each such general partner is a U.S. citizen, whose principal occupation is general partner of CCP and whose principal business office address (except for Mr. Soghikian) is c/o Chase Capital Partners, 380 Madison Avenue, 12th Floor, New York, New York 10017. John R. Baron Mitchell J. Blutt, M.D. Arnold L. Chavkin Michael R. Hannon Donald J. Hofmann Stephen P. Murray John M. B. O'Connor Brian J. Richmand Shahan D. Soghikian Jeffrey C. Walker Damion E. Wicker, M.D. Mr. Soghikian's principal business office address is c/o Chase Capital Partners, 125 London Wall, London EC2Y5AJ, England. Jeffrey C. Walker is the managing general partner of CCP. The remaining general partners of CCP are Chase Capital Corporation (f/k/a Chemical Capital Corporation), a New York corporation ("Chase Capital"), CCP Principals, L.P. (f/k/a CVP Principals, L.P.), a Delaware limited partnership ("Principals") and CCP European Principals, L.P., a Delaware limited partnership ("European Principals"), each of whose principal business office is located at the same address as CVCA. Chase Capital is a wholly-owned subsidiary of The Chase Manhattan Corporation (f/k/a Chemical Banking Corporation), a Delaware corporation. The general partner of each of Principals and European Principals is Chase Capital. Set forth in Schedule A hereto and incorporated herein by reference are the names, business addresses and principal occupations or employments of each executive officer and director of Chase Capital, each of whom is a U.S. citizen. The Chase Manhattan Corporation ("Chase") is a Delaware corporation engaged (primarily through subsidiaries) in the commercial banking business with its principal office located at 270 Park Avenue, New York, New York 10017. Set forth in Schedule B hereto and incorporated herein by reference are the names, business addresses, principal occupations and employments of each executive officer and director of Chase, each of whom is a U.S. Citizen. Page 6 of 10 Pages SCHEDULE 13G ------------ Issuer: Landec Corporation CUSIP Number: 514766100 - ------ ------------ - -------------------------------------------------------------------------------- SCHEDULE A ---------- CHASE CAPITAL CORPORATION ------------------------- Executive Officers ------------------ Chief Executive Officer William B. Harrison, Jr.* President Jeffrey C. Walker** Executive Vice President Mitchell J. Blutt, M.D.** Vice President & Secretary Gregory Meridith* Vice President George E. Kelts** Assistant Secretary Robert C. Carroll* Directors --------- William B. Harrison, Jr.* Jeffrey C. Walker** - ---------- * Principal occupation is employee and/or officer of Chase. Business address is c/o The Chase Manhattan Corporation, 270 Park Avenue, New York, New York 10017. ** Principal occupation is employee of Chase and/or general partner of CCP. Business address is c/o Chase Capital Partners, 380 Madison Avenue, 12th Floor, New York, NY 10017. Page 7 of 10 Pages SCHEDULE 13G ------------ Issuer: Landec Corporation CUSIP Number: 514766100 - ------ ------------ - -------------------------------------------------------------------------------- SCHEDULE B ---------- THE CHASE MANHATTAN CORPORATION ------------------------------- Executive Officers* ------------------ Walter V. Shipley, Chairman Thomas G. Labrecque, President William B. Harrison, Jr., Vice Chairman Donald L. Boudreau, Senior Executive Vice President Marc Shapiro, Senior Executive Vice President Joseph G. Sponholz, Senior Executive Vice President Directors** Principal Occupation or Employment; Name Business or Residence Address ---- ----------------------------- Hans W. Becherer Chairman of the Board Chief Executive Officer Deere & Company 8601 John Deere Road Moline, IL 61265 Frank A. Bennack, Jr. President and Chief Executive Officer The Hearst Corporation 959 Eighth Avenue New York, NY 10019 Susan V. Berresford President The Ford Foundation 320 East 43rd Street New York, NY 10017 M. Anthony Burns Chairman, President and CEO Ryder System, Inc. 3600 N.W. S2nd Avenue Miami, FL 33166 - -------- * Principal occupation is executive officer and/or employee of The Chase Manhattan Bank. Business address is c/o The Chase Manhattan Bank, 270 Park Avenue, New York, New York 10017. Each executive officer of Chase is a U.S. citizen. ** Each of the persons named below is a citizen of the United States of America. Page 8 of 10 Pages SCHEDULE 13G ------------ Issuer: Landec Corporation CUSIP Number: 514766100 - ------ ------------ - -------------------------------------------------------------------------------- Principal Occupation or Employment; Name Business or Residence Address ---- ----------------------------- H. Laurance Fuller Chairman of the Board and Chief Executive Officer Amoco Corporation 200 East Randolph Drive Chicago, IL 60601 Melvin R. Goodes Chairman of the Board and Chief Executive Officer Warner-Lambert Company 201 Tabor Road Morris Plains, NJ 07950 William H. Gray, III President and Chief Executive Officer The College Fund/UNCF 8260 Willow Oaks Corporate Drive P.O. Box 10444 Fairfax, VA 22031 George V. Grune Chairman of the Board and Chief Executive Officer The Reader's Digest Association, Inc. Chairman of the Board The DeWitt Wallace-Reader's Digest Fund Lila Wallace-Reader's Digest Fund Reader's Digest Road Pleasantville, NY 10570 William B. Harrison, Jr. Vice Chairman of the Board The Chase Manhattan Corporation 270 Park Avenue, 8th Floor New York, NY 10017-2070 Harold S. Hook Retired Chairman of the Board American General Corporation 2929 Allen Parkway Houston, TX 77019 Helene L. Kaplan Of Counsel Skadden, Arps, Slate, Meagher & Flom 919 Third Avenue-Room 29-72 New York, NY 10022 Thomas G. Labrecque President The Chase Manhattan Corporation 270 Park Avenue, 8th Floor New York, NY 10017-2070 Page 9 of 10 Pages SCHEDULE 13G ------------ Issuer: Landec Corporation CUSIP Number: 514766100 - ------ ------------ - -------------------------------------------------------------------------------- Principal Occupation or Employment; Name Business or Residence Address ---- ----------------------------- Henry B. Schacht Retired Chairman of the Board and Chief Executive Officer Lucent Technologies, Inc. 600 Mountain Avenue - Room 6A511 Murray Hill, NJ 07974 Walter V. Shipley Chairman of the Board The Chase Manhattan Corporation 270 Park Avenue, 8th Floor New York, NY 10017-2070 Andrew C. Sigler Retired Chairman of the Board and Chief Executive Officer Champion International Corporation 1 Champion Plaza Stamford, CT 06921 John R. Stafford Chairman, President and Chief Executive Officer American Home Products Corporation Five Giralda Farms Madison, NJ 07940 Marina v.N. Whitman Professor of Business Administration and Public Policy The University of Michigan School of Public Policy 411 Lorch Hall, 611 Tappan Street Ann Arbor, MI 48109-1220 Page 10 of 10 Pages